Last updated: 4 months ago
NeuroSense Therapeutics Ltd. Files Form 6-K: Major ALS Treatment Update!
Explore NeuroSense Therapeutics Ltd.'s latest Form 6-K revealing a binding term sheet for PrimeC in ALS treatment, signaling potential advancements and market impact.